Christoph Stein

Active 1988–2026

154
Papers
24,700
Citations
95
h-index
143
i10-index

Citations

Citations per year for Christoph Stein1983: 2 citations1988: 6 citations1989: 5 citations1990: 21 citations1991: 34 citations1992: 43 citations1993: 57 citations1994: 64 citations1995: 123 citations1996: 70 citations1997: 124 citations1998: 113 citations1999: 125 citations2000: 75 citations2001: 150 citations2002: 134 citations2003: 250 citations2004: 229 citations2005: 242 citations2006: 314 citations2007: 233 citations2008: 155 citations2009: 325 citations2010: 142 citations2011: 200 citations2012: 112 citations2013: 199 citations2014: 110 citations2015: 130 citations2016: 104 citations2017: 132 citations2018: 142 citations2019: 446 citations2020: 568 citations2021: 389 citations2022: 283 citations2023: 201 citations2024: 335 citations2025: 121 citations2026: 4 citations1984–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,004 citing papers, 33.1% of this breakdownUnited Kingdom: 467 citing papers, 7.7% of this breakdownGermany: 417 citing papers, 6.9% of this breakdownChina: 349 citing papers, 5.8% of this breakdownCanada: 277 citing papers, 4.6% of this breakdownItaly: 229 citing papers, 3.8% of this breakdownAustralia: 176 citing papers, 2.9% of this breakdownFrance: 174 citing papers, 2.9% of this breakdownJapan: 138 citing papers, 2.3% of this breakdownSpain: 129 citing papers, 2.1% of this breakdownDenmark: 126 citing papers, 2.1% of this breakdownNetherlands: 112 citing papers, 1.8% of this breakdown
0%33.1%Other 24%

Fields

  • Medicine67.1%
  • Neuroscience12.8%
  • Biochemistry, Genetics and Molecular Biology9.8%
  • Immunology and Microbiology3.2%
  • Pharmacology, Toxicology and Pharmaceutics2.3%
  • Nursing0.6%
  • Other4.2%

Topics

  • Pain Mechanisms and Treatments9.7%
  • Neuropeptides and Animal Physiology6.4%
  • Receptor Mechanisms and Signaling2.5%
  • Pain Management and Opioid Use2.4%
  • Anesthesia and Pain Management1.9%
  • Rheumatoid Arthritis Research and Therapies1.8%
  • Other75.3%

Coauthors

All papers

Open in search
  1. Opioid Receptors

    Authors: - Annual Review of Medicine 2015 cited by 462

  2. Azithromycin and the Risk of Cardiovascular Death

    Authors: , , , , - New England Journal of Medicine 2012 cited by 968

  3. Heart Failure Risk Associated With Rheumatoid Arthritis–Related Chronic Inflammation

    Authors: , , , , , , , , - Journal of the American Heart Association 2020 cited by 114

  4. Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups

    Authors: , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2020 cited by 173

  5. A nontoxic pain killer designed by modeling of pathological receptor conformations

    Authors: , , , , , , , , , , , - Science 2017 cited by 228

  6. New concepts in opioid analgesia

    Authors: - Expert Opinion on Investigational Drugs 2018 cited by 171

  7. Advances in Neuropathic Pain

    Authors: , , , , , , , , , , , , , , , , , , , , - Archives of Neurology 2003 cited by 1,209

  8. Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain

    Authors: , , , , - JAMA 2016 cited by 369

  9. Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects

    Authors: , , , , , , , , , , , , , , , , , , - Gut 2021 cited by 48

  10. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: Evidence for a regulatory function of nerve growth factor in vivo

    Authors: , , - Neuroscience 1992 cited by 601

  11. An automated database case definition for serious bleeding related to oral anticoagulant use

    Authors: , , , , , - Pharmacoepidemiology and Drug Safety 2011 cited by 356

  12. LPA Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dan M. Roden, Ronald M. Krauss, Joshua C. Denny - Circulation 2018 cited by 92

  13. Attacking pain at its source: new perspectives on opioids

    Authors: , , - Nature Medicine 2003 cited by 595

  14. Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: Alterations in behavior and nociceptive thresholds

    Authors: , , - Pharmacology Biochemistry and Behavior 1988 cited by 346

  15. Modulation of Peripheral Sensory Neurons by the Immune System: Implications for Pain Therapy

    Authors: , - Pharmacological Reviews 2011 cited by 176

  16. Association Between a Common, Benign Genotype and Unnecessary Bone Marrow Biopsies Among African American Patients

    Authors: , , , , , , , , , , , , , , , , , - JAMA Internal Medicine 2021 cited by 37

  17. Isolevuglandins disrupt PU.1-mediated C1q expression and promote autoimmunity and hypertension in systemic lupus erythematosus

    Authors: , , , , , , , , , , , , , , , , , , , - JCI Insight 2022 cited by 31

  18. Phenome-Wide Association Study of UMOD Gene Variants and Differential Associations With Clinical Outcomes Across Populations in the Million Veteran Program a Multiethnic Biobank

    Authors: , , , , , , , , , , , , , - Kidney International Reports 2022 cited by 19

  19. Increased coronary‐artery atherosclerosis in rheumatoid arthritis: Relationship to disease duration and cardiovascular risk factors

    Authors: , , , , , , , , - Arthritis & Rheumatism 2005 cited by 350

  20. μ-Opioid Receptor Activation Modulates Transient Receptor Potential Vanilloid 1 (TRPV1) Currents in Sensory Neurons in A Model of Inflammatory Pain

    Authors: , , , , , , , - Molecular Pharmacology 2006 cited by 148

  21. Cannabidivarin for HIV‐Associated Neuropathic Pain: A Randomized, Blinded, Controlled Clinical Trial

    Authors: , , , , , , , - Clinical Pharmacology & Therapeutics 2020 cited by 40

  22. A recombinant trispecific single‐chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting

    Authors: , , , , , , , , , , , - British Journal of Haematology 2010 cited by 130

  23. Modulation of Transient Receptor Vanilloid 1 Activity by Transient Receptor Potential Ankyrin 1

    Authors: , , - Molecular Pharmacology 2013 cited by 97

  24. Targeting pain and inflammation by peripherally acting opioids

    Authors: - Frontiers in Pharmacology 2013 cited by 88